189075709	189075709	CD	B-NP	O
|	|	NN	I-NP	O
GH	GH	NN	I-NP	O
|	|	NN	I-NP	O
25936617	25936617	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3692041	3692041	CD	B-NP	O
|	|	CC	I-NP	O
10/20/2003	10/20/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/20/2003	10/20/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
RANDELL	RANDELL	NNP	B-NP	O
SOUPHOM	SOUPHOM	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Dilated	Dilate	VBN	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

SECONDARY	SECONDARY	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
Right	Right	NN	B-NP	O
foot	foot	NN	I-NP	O
osteomylitis	osteomylitis	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
calf	calf	NN	B-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
nonsustained	nonsustained	JJ	B-NP	O
VT	VT	NN	I-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
occipital	occipital	NN	B-NP	O
CVA	CVA	NNP	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
vocal	vocal	JJ	B-NP	O
cord	cord	NN	I-NP	O
paralysis	paralysis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
renal	renal	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
54-year-old	54-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
nonischemic	nonischemic	JJ	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
weight	weight	NN	B-NP	O
gain	gain	NN	I-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
azotemia	azotemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
alcohol	alcohol	NN	B-NP	O
with	with	IN	B-PP	O
incomplete	incomplete	JJ	B-NP	O
cardiology	cardiology	NN	I-NP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
performed	perform	VBN	B-VP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
,	,	,	O	O
PA	PA	NN	B-NP	O
pressure	pressure	NN	I-NP	O
49	49	CD	I-NP	O
of	of	IN	B-PP	O
28	28	CD	B-NP	O
,	,	,	O	O
pulmonary	pulmonary	JJ	B-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
26	26	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
of	of	IN	B-PP	O
4	4	CD	B-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	O
stress	stress	NN	I-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
2002	2002	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
lasted	last	VBD	B-VP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
30	30	CD	B-NP	O
seconds	second	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
read	read	VB	I-VP	O
anaerobic	anaerobic	JJ	B-NP	O
threshold	threshold	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
ZO2	ZO2	NN	I-NP	B-protein
of	of	IN	B-PP	O
11.1	11.1	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
2003	2003	CD	I-NP	O
with	with	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
LV	LV	NN	B-NP	B-protein
EDD	EDD	NN	I-NP	I-protein
of	of	IN	B-PP	O
65	65	CD	B-NP	O
and	and	CC	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
moderate	moderate	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
and	and	CC	O	O
severe	severe	JJ	B-NP	O
TR	TR	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
,	,	,	O	O
seretide	seretide	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diuretics	diuretic	NNS	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Course	Course	NN	B-NP	O
complicated	complicate	VBN	B-VP	O
by	by	IN	B-PP	O
left	left	JJ	B-NP	O
leg	leg	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
renal	renal	JJ	B-NP	O
functioning	functioning	NN	I-NP	O
on	on	IN	B-PP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
weeks	week	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
presentation	presentation	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
clinic	clinic	NN	B-NP	O
with	with	IN	B-PP	O
fluid	fluid	NN	B-NP	O
retention	retention	NN	I-NP	O
,	,	,	O	O
diuretics	diuretic	NNS	B-NP	O
were	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
worsening	worsen	VBG	I-VP	O
renal	renal	JJ	B-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
so	so	IN	O	O
diuretics	diuretic	NNS	B-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
now	now	RB	B-VP	O
presented	present	VBN	I-VP	O
with	with	IN	B-PP	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
leg	leg	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
draining	drain	VBG	B-VP	O
foot	foot	NN	B-NP	O
wound	wound	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Hypertension	Hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vasculare	vasculare	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	VBD	B-VP	O
transmetatarsal	transmetatarsal	JJ	B-NP	O
amputations	amputation	NNS	I-NP	O
,	,	,	O	O
osteomyelitis	osteomyelitis	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
VT.	VT.	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
declined	decline	VBD	B-VP	O
ICD	ICD	NN	B-NP	B-protein
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
occipital	occipital	NN	B-NP	O
CVA	CVA	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
q.o.d.	q.o.d.	NN	I-NP	O
,	,	,	O	O
Imdur	Imdur	NNP	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
was	be	VBD	B-VP	O
being	be	VBG	I-VP	O
held	hold	VBN	I-VP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
carvedilol	carvedilol	NN	B-NP	O
3.125	3.125	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Glucophage	Glucophage	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glyburide	glyburide	NN	B-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Father	Father	NN	B-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
in	in	IN	B-PP	O
80s	80	NNS	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
currently	currently	RB	B-ADVP	O
lives	live	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
roommate	roommate	NN	I-NP	O
.	.	.	O	O

Family	Family	RB	B-ADVP	O
is	be	VBZ	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
strange	strange	JJ	I-ADJP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
recently	recently	RB	B-ADJP	O
more	more	RBR	I-ADJP	O
involved	involve	VBN	I-ADJP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
tobacco	tobacco	NN	I-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
moderate	moderate	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
consumption	consumption	NN	I-NP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
tired	tire	VBN	I-NP	O
older	old	JJR	I-NP	O
man	man	NN	I-NP	O
lying	lie	VBG	B-VP	O
at	at	IN	B-PP	O
30	30	CD	B-NP	O
degrees	degree	NNS	I-NP	O
with	with	IN	B-PP	O
profound	profound	JJ	B-NP	O
fatigue	fatigue	NN	I-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
84/60	84/60	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
100	100	CD	I-NP	O
and	and	CC	O	O
regular	regular	JJ	B-NP	O
,	,	,	O	O
weight	weight	NN	B-NP	O
102.4	102.4	CD	I-NP	O
kg	kg	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
temperature	temperature	NN	B-NP	B-protein
99.4	99.4	CD	I-NP	I-protein
.	.	.	O	O

Mild	Mild	JJ	B-NP	O
pallor	pallor	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
scleral	scleral	JJ	I-NP	O
icterus	icterus	NN	I-NP	O
.	.	.	O	O

JVP	JVP	NN	B-NP	B-protein
to	to	TO	B-PP	O
the	the	DT	B-NP	O
angle	angle	NN	I-NP	O
of	of	IN	B-PP	O
jaw	jaw	NN	B-NP	B-protein
.	.	.	O	O

Coarse	Coarse	NN	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
without	without	IN	B-PP	O
wheeze	wheeze	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
irregular	irregular	JJ	I-NP	O
and	and	CC	I-NP	O
soft	soft	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
,	,	,	O	O
gallop	gallop	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rub	rub	NN	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
reveals	reveal	VBZ	B-VP	O
decreased	decrease	VBN	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
-	-	HYPH	O	O
four	four	CD	B-NP	O
fingerbreadths	fingerbreadth	NNS	I-NP	O
below	below	IN	B-PP	O
right	right	JJ	B-NP	O
costal	costal	JJ	I-NP	O
margin	margin	NN	I-NP	O
,	,	,	O	O
nonpulsatile	nonpulsatile	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
guarding	guarding	NN	I-NP	O
or	or	CC	I-NP	O
rebound	rebound	NN	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
to	to	TO	B-PP	O
thighs	thigh	NNS	B-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
129	129	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.2	4.2	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-cell_line
133	133	CD	I-NP	I-cell_line
,	,	,	O	O
creatinine	creatinine	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
31.9	31.9	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
15.8	15.8	CD	B-NP	O
with	with	IN	B-PP	O
89	89	CD	B-NP	O
%	%	NN	I-NP	O
polys	poly	NNS	I-NP	O
,	,	,	O	O
8	8	CD	B-NP	O
bands	band	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
INR	INR	NN	B-NP	B-protein
4.6	4.6	CD	I-NP	I-protein
,	,	,	O	O
albumin	albumin	NN	B-NP	O
2.7	2.7	CD	I-NP	O
and	and	CC	O	O
total	total	JJ	B-NP	O
bilirubin	bilirubin	NN	I-NP	O
3.4	3.4	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
normal	normal	JJ	B-NP	B-protein
transaminases	transaminase	NNS	I-NP	I-protein
.	.	.	O	O

ECG	ECG	NN	B-NP	O
showed	show	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
at	at	IN	B-PP	O
90	90	CD	B-NP	O
per	per	IN	B-PP	O
minute	minute	NN	B-NP	O
,	,	,	O	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
,	,	,	O	O
poor	poor	JJ	B-NP	O
R-wave	R-wave	NN	I-NP	O
progression	progression	NN	I-NP	O
with	with	IN	B-PP	O
QRS	QRS	NN	B-NP	B-protein
widening	widening	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nonspecific	nonspecific	JJ	B-NP	O
T-wave	T-wave	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Cardiology	Cardiology	NNP	B-NP	O
Service	Service	NNP	I-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
volume	volume	NN	I-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
dilated	dilated	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
lower	low	JJR	B-NP	O
extremity	extremity	NN	I-NP	O
infections	infection	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
summarized	summarize	VBN	I-VP	O
briefly	briefly	RB	B-ADVP	O
by	by	IN	B-PP	O
dates	date	NNS	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
11/21/03	11/21/03	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
progression	progression	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	O
for	for	IN	B-PP	O
debridement	debridement	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
10/8/03	10/8/03	CD	B-NP	O
,	,	,	O	O
Diuril	Diuril	NNP	B-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
from	from	IN	B-PP	O
2.6	2.6	CD	B-NP	O
to	to	TO	B-PP	O
3.6	3.6	CD	B-NP	O
and	and	CC	O	O
diuretics	diuretic	NNS	B-NP	O
were	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
6/25/03	6/25/03	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
retuned	retune	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	O
for	for	IN	B-PP	O
revision	revision	NN	B-NP	O
of	of	IN	B-PP	O
right	right	JJ	B-NP	O
wound	wound	NN	I-NP	O
infection	infection	NN	I-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
further	further	JJ	I-NP	O
transmetatarsal	transmetatarsal	JJ	I-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
malaise	malaise	NN	B-NP	O
coincident	coincident	JJ	B-ADJP	O
with	with	IN	B-PP	O
20-beat	20-beat	JJ	B-NP	O
run	run	NN	I-NP	O
of	of	IN	B-PP	O
VT	VT	NN	B-NP	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
syncope	syncope	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
stetting	stetting	NN	I-NP	O
of	of	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
VT	VT	NN	I-NP	O
terminated	terminate	VBN	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
,	,	,	O	O
unfortunately	unfortunately	RB	B-ADVP	O
still	still	RB	B-ADVP	O
required	require	VBD	B-VP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
dobutamine	dobutamine	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

On	On	IN	B-PP	O
11/2/03	11/2/03	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
OR	OR	NN	I-NP	O
for	for	IN	B-PP	O
debridement	debridement	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-ADJP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
80s	80	NNS	B-NP	O
going	go	VBG	B-VP	O
to	to	TO	B-PP	O
60s	60	NNS	B-NP	O
over	over	IN	B-PP	O
palp	palp	NN	B-NP	O
with	with	IN	B-PP	O
decrease	decrease	NN	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
briefly	briefly	NN	I-NP	O
and	and	CC	O	O
did	do	VBD	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
ionotropes	ionotrope	NNS	B-NP	O
and	and	CC	I-NP	O
diuretics	diuretic	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
decrease	decrease	NN	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
on	on	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
diuretic	diuretic	JJ	I-NP	O
doses	dose	NNS	I-NP	O
and	and	CC	I-NP	O
ionotropes	ionotrope	NNS	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
6/5/03	6/5/03	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
renal	renal	JJ	I-NP	O
surgery	surgery	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
be	be	VB	B-VP	O
stopped	stop	VBN	I-VP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
enhance	enhance	VB	I-VP	O
renal	renal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
be	be	VB	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
promptly	promptly	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
cardiogenic	cardiogenic	JJ	B-NP	O
shock	shock	NN	I-NP	O
with	with	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
again	again	RB	I-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
with	with	IN	B-PP	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
60s	60	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
ashen	ashen	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
cold	cold	JJ	I-ADJP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
required	require	VBN	I-VP	O
dobutamine	dobutamine	NN	B-NP	O
between	between	IN	B-PP	O
1	1	CD	B-NP	O
and	and	CC	I-NP	O
2.5	2.5	CD	I-NP	O
mcg/kg/minute	mcg/kg/minute	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
CVVH	CVVH	NN	B-NP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
the	the	DT	B-NP	O
FL	FL	NN	I-NP	O
rates	rate	NNS	I-NP	O
between	between	IN	B-PP	O
15	15	CD	B-NP	B-DNA
and	and	CC	I-NP	I-DNA
200	200	CD	I-NP	I-DNA
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/28/03	4/28/03	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
hoarseness	hoarseness	NN	B-NP	O
.	.	.	O	O

Otolaryngology	Otolaryngology	NN	B-NP	O
evaluation	evaluation	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
paralyzed	paralyzed	JJ	B-NP	O
left	left	JJ	I-NP	O
vocal	vocal	JJ	I-NP	O
cords	cord	NNS	I-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
atrial	atrial	JJ	B-NP	O
enlargement	enlargement	NN	I-NP	O
or	or	CC	O	O
potentially	potentially	RB	B-ADVP	O
the	the	DT	B-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
IJ	IJ	NN	I-NP	O
catheter	catheter	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
5/6/03	5/6/03	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
for	for	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	I-NP	O
CVVH	CVVH	NN	I-NP	O
access	access	NN	I-NP	O
with	with	IN	B-PP	O
plan	plan	NN	B-NP	O
initiation	initiation	NN	I-NP	O
of	of	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/30/03	10/30/03	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
first	first	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
tolerated	tolerate	VBD	B-VP	O
this	this	DT	B-NP	O
procedure	procedure	NN	I-NP	O
well	well	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
PICC	PICC	NN	I-NP	B-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
a	a	DT	B-NP	O
pneumococcal	pneumococcal	JJ	I-NP	O
vaccine	vaccine	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
a.	a.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
advanced	advance	VBN	B-NP	O
dilated	dilated	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
overall	overall	JJ	I-NP	O
prognosis	prognosis	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
aggressive	aggressive	JJ	B-NP	O
diuresis	diuresis	NN	I-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
improve	improve	VB	I-VP	O
his	his	PRP$	B-NP	O
position	position	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
?	?	.	O	O
?	?	.	O	O
?	?	.	O	O
?	?	.	O	O
curve	curve	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
by	by	IN	B-PP	O
CVVH	CVVH	NN	B-NP	B-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
now	now	RB	I-VP	O
being	be	VBG	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
hemodialysis	hemodialysis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
beyond	beyond	IN	B-PP	O
less	less	JJR	B-NP	O
invasive	invasive	JJ	I-NP	O
measures	measure	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
digoxin	digoxin	NN	B-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
dobutamine	dobutamine	NN	B-ADJP	O
dependent	dependent	JJ	I-ADJP	O
.	.	.	O	O

b.	b.	RB	B-ADVP	O
Ischemia	Ischemia	NNP	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
ischemic	ischemic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
incorporate	incorporate	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

c.	c.	JJ	B-NP	O
Rhythm	Rhythm	NN	I-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
AF	AF	NN	I-NP	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
ectopy	ectopy	NN	I-NP	O
and	and	CC	I-NP	O
VT	VT	NN	I-NP	O
on	on	IN	B-PP	O
dobutamine	dobutamine	NN	B-NP	O
,	,	,	O	O
currently	currently	RB	B-VP	O
loaded	load	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
further	further	JJ	I-NP	O
events	event	NNS	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
osteomylitis	osteomylitis	NN	I-NP	O
,	,	,	O	O
currently	currently	RB	B-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
six-week	six-week	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Diflucan	Diflucan	NNP	B-NP	O
for	for	IN	B-PP	O
complicated	complicate	VBN	B-NP	O
osteomyelitis	osteomyelitis	NN	I-NP	O
,	,	,	O	O
end	end	NN	B-NP	O
date	date	NN	I-NP	O
is	be	VBZ	B-VP	O
on	on	IN	B-PP	O
9/27/03	9/27/03	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
pneumococcal	pneumococcal	JJ	B-NP	O
vaccine	vaccine	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
up-to-date	up-to-date	JJ	B-ADJP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
flu	flu	NN	I-NP	O
vaccine	vaccine	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
progressive	progressive	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
flow	flow	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
kidneys	kidney	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
exacerbated	exacerbate	VBN	I-VP	O
by	by	IN	B-PP	O
ACE	ACE	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
increasing	increase	VBG	B-VP	O
doses	dose	NNS	B-NP	O
of	of	IN	B-PP	O
diuretics	diuretic	NNS	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
ineffective	ineffective	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
obtain	obtain	VB	I-VP	O
increased	increase	VBN	B-NP	O
amounts	amount	NNS	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
output	output	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
he	he	PRP	B-NP	O
comes	come	VBZ	B-VP	O
on	on	IN	B-PP	O
strongly	strongly	RB	B-ADVP	O
through	through	IN	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
may	may	MD	B-VP	O
regain	regain	VB	I-VP	O
some	some	DT	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
predicted	predict	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
require	require	VB	I-VP	O
hemodialysis	hemodialysis	NN	B-NP	O
for	for	IN	B-PP	O
remainder	remainder	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
life	life	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
this	this	DT	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
tunneled	tunnel	VBN	I-NP	O
catheter	catheter	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
for	for	IN	B-PP	O
access	access	NN	B-NP	O
on	on	IN	B-PP	O
10/20/03	10/20/03	CD	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Vascular	Vascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
now	now	RB	B-ADVP	O
status	statu	VBZ	B-VP	O
post	post	IN	B-PP	O
transmetatarsal	transmetatarsal	JJ	B-NP	O
amputation	amputation	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
open	open	JJ	I-NP	O
wound	wound	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
foot	foot	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
calf	calf	NN	I-NP	O
ulcer	ulcer	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
planned	plan	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Plastic	Plastic	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
for	for	IN	B-PP	O
final	final	JJ	B-NP	O
plans	plan	NNS	I-NP	O
whether	whether	IN	B-SBAR	O
a	a	DT	B-NP	O
flap	flap	NN	I-NP	O
or	or	CC	I-NP	O
healing	healing	NN	I-NP	O
by	by	IN	B-PP	O
secondary	secondary	JJ	B-NP	O
retention	retention	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
depressed	depress	VBN	I-VP	O
with	with	IN	B-PP	O
frequent	frequent	JJ	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
exceedingly	exceedingly	RB	B-ADJP	O
fearful	fearful	JJ	I-ADJP	O
of	of	IN	B-PP	O
dying	die	VBG	B-NP	O
,	,	,	O	O
and	and	CC	O	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
sleep	sleep	VB	I-VP	O
with	with	IN	B-PP	O
light	light	JJ	B-ADJP	O
off	off	IN	B-PP	O
or	or	CC	I-PP	O
with	with	IN	I-PP	O
drapes	drape	NNS	B-NP	O
pole	pole	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
believe	believe	VB	I-VP	O
that	that	IN	B-SBAR	O
if	if	IN	B-SBAR	O
he	he	PRP	B-NP	O
falls	fall	VBZ	B-VP	O
asleep	asleep	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
will	will	MD	B-VP	O
no	no	RB	I-VP	O
longer	longer	RB	I-VP	O
wake	wake	VB	I-VP	O
up	up	RP	B-PRT	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Psychiatry	Psychiatry	NNP	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
suggested	suggest	VBD	B-VP	O
starting	start	VBG	I-VP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Zyprexa	Zyprexa	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
has	have	VBZ	B-VP	O
greatly	greatly	RB	I-VP	O
improved	improve	VBN	I-VP	O
his	his	PRP$	B-NP	O
mood	mood	NN	I-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
from	from	IN	B-PP	O
this	this	DT	B-NP	O
regard	regard	NN	I-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
failed	fail	VBD	B-VP	O
a	a	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
stimulation	stimulation	NN	B-NP	O
test	test	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
.	.	.	O	O

When	When	WRB	B-ADVP	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
down	down	RP	B-PRT	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
periods	period	NNS	I-NP	O
of	of	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
again	again	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remains	remain	VBZ	B-VP	O
on	on	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
hydrocortisone	hydrocortisone	NN	B-NP	O
.	.	.	O	O

Etiology	Etiology	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
adrenal	adrenal	JJ	I-NP	O
insufficieny	insufficieny	NN	I-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
.	.	.	O	O

Additionally	Additionally	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
diabetes	diabete	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
hypoglycemic	hypoglycemic	JJ	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
this	this	DT	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
transitioned	transitione	VBN	I-VP	O
over	over	RP	B-PRT	O
to	to	TO	B-PP	O
insulin	insulin	NN	B-NP	B-protein
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
standing	standing	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
lispro	lispro	NN	I-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
TPN	TPN	NN	B-NP	B-protein
for	for	IN	B-PP	O
quite	quite	RB	B-NP	O
severe	severe	JJ	I-NP	O
malnutrition	malnutrition	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
now	now	RB	B-ADVP	O
has	have	VBZ	B-VP	O
increasing	increase	VBG	I-VP	O
albumin	albumin	NN	B-NP	O
with	with	IN	B-PP	O
increased	increase	VBN	B-NP	O
appetite	appetite	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
tolerating	tolerate	VBG	I-VP	O
more	more	JJR	B-NP	O
food	food	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
nectar	nectar	JJ	B-NP	O
thick	thick	JJ	I-NP	O
liquids	liquid	NNS	I-NP	O
for	for	IN	B-PP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-VP	O
left	left	VB	I-VP	O
vocal	vocal	JJ	B-NP	O
cord	cord	NN	I-NP	O
paralysis	paralysis	NN	I-NP	O
and	and	CC	O	O
visualized	visualize	VBD	B-VP	O
aspiration	aspiration	NN	B-NP	O
on	on	IN	B-PP	O
barium	barium	NN	B-NP	O
swallow	swallow	NN	I-NP	O
by	by	IN	B-PP	O
ENT	ENT	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
currently	currently	RB	B-ADVP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
discharge	discharge	NN	B-NP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
dobutamine	dobutamine	NN	I-NP	O
and	and	CC	O	O
frequent	frequent	JJ	B-NP	O
and	and	CC	I-NP	O
careful	careful	JJ	I-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Mongiovi	Mongiovi	NNP	I-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-1922327	4-1922327	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
KAEDING	KAEDING	NNP	B-NP	O
,	,	,	O	O
DAMIAN	DAMIAN	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ROTHBERG	ROTHBERG	NNP	B-NP	O
,	,	,	O	O
CLETUS	CLETUS	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
2549097	2549097	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/30/03	10/30/03	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/25/03	8/25/03	CD	B-NP	O

